A Study of V118E in Healthy Participants (V118E-003)
Start Date
10/8/2025
Completion Date
7/6/2027
Summary
Researchers are looking for new vaccines to prevent illnesses caused by a type of bacteria called Streptococcus pneumoniae. There are many different types of Streptococcus pneumoniae bacteria, called serotypes. Vaccines contain small parts of certain serotypes. These parts will not cause an infection but help the body create antibodies (proteins) to fight the bacteria. PREVNAR 20™ is a vaccine given to help to prevent disease from Streptococcus pneumoniae bacteria. Researchers designed a new vaccine, V118E, to help prevent disease from Streptococcus pneumoniae bacteria. The goal of this study is to learn how safe V118 formulation E is in Healthy Adults and how well people tolerate it.
Eligibility Criteria
Age Range: 18 years to 49 years
Interventions
V118E
PREVNAR 20™
Saline
Conditions
Locations
Velocity Clinical Research, Hallandale Beach ( Site 0003)
Hallandale, Florida 33009
United States
QPS-MRA, LLC-Early Phase ( Site 0002)
South Miami, Florida 33143
United States
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0004)
Springfield, Missouri 65802
United States
University of Texas Medical Branch ( Site 0001)
Galveston, Texas 77555-1115
United States